Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuerk, E. E.
Right arrow Articles by Wegner, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuerk, E. E.
Right arrow Articles by Wegner, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 7, 4774-4782, February 18, 2000

Protein Stability and Domain Topology Determine the Transcriptional Activity of the Mammalian Glial Cells Missing Homolog, GCMb*

Elisabeth E. TuerkDagger , Jörg SchreiberDagger , and Michael Wegner§

From the Zentrum für Molekulare Neurobiologie, Universität Hamburg, Martinistrasse 52, D-20246 Hamburg, Germany

The glial cells missing (GCM) family of transcription factors consists of Drosophila GCM and the mammalian proteins GCMa and GCMb. They are expressed in a highly restricted manner during development and are known or assumed to be important regulators of developmental fate decisions. As the biochemical properties of GCMb have not been studied so far, we have undertaken a detailed structure-function analysis of the mouse GCMb (mGCMb) protein. DNA-binding specificity was very similar to that of other GCM proteins. Nevertheless, mGCMb was only a weak transcriptional activator in a number of different tissue culture systems. Interestingly, this was not due to an intrinsic absence of transactivation potential. In effect, we were able to identify two separate transactivation domains within mGCMb, one carboxyl-terminally adjacent to the DNA-binding domain and the second within the extreme carboxyl terminus. Activity of both transactivation domains was, however, modulated by an inhibitory region unique to mGCMb and located between the two transactivation domains. Furthermore, pulse-chase experiments proved that the mGCMb protein has a half-life approximately four times shorter than mGCMa. Introduction of the above mentioned inhibitory domain of mGCMb into mGCMa shortened the half-life of mGCMa to a value typical of mGCMb with a concomitant reduction in transactivation potential. Given the strong correlation between protein stability and transactivation potential, functional differences between the two mammalian GCM homologs are likely due to differences in stability with a single inhibitory region in mGCMb being involved in the reduction of both.


* This work was supported by Grant SFB 444 from the Deutsche Forschungsgemeinschaft (to M. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Contributed equally to this work.

§ To whom correspondence should be addressed. Tel.: 49 40 42803 6274; Fax: 49 40 42803 6602; E-mail: wegner@plexus.uke.uni-hamburg.de.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Mannstadt, G. Bertrand, M. Muresan, G. Weryha, B. Leheup, S. R. Pulusani, B. Grandchamp, H. Juppner, and C. Silve
Dominant-Negative GCMB Mutations Cause an Autosomal Dominant Form of Hypoparathyroidism
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3568 - 3576.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. W. Schubert, A. Abendroth, K. Kilian, T. Vogler, B. Mayr, I. Knerr, and S. Hashemolhosseini
bZIP-Type transcription factors CREB and OASIS bind and stimulate the promoter of the mammalian transcription factor GCMa/Gcm1 in trophoblast cells
Nucleic Acids Res., June 1, 2008; 36(11): 3834 - 3846.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Maret, C. Ding, S. L. Kornfield, and M. A. Levine
Analysis of the GCM2 Gene in Isolated Hypoparathyroidism: A Molecular and Biochemical Study
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1426 - 1432.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Thomee, S. W. Schubert, J. Parma, P. Q. Le, S. Hashemolhosseini, M. Wegner, and M. J. Abramowicz
GCMB Mutation in Familial Isolated Hypoparathyroidism with Residual Secretion of Parathyroid Hormone
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2487 - 2492.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
L Baumber, C Tufarelli, S Patel, P King, C A Johnson, E R Maher, and R C Trembath
Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism
J. Med. Genet., May 1, 2005; 42(5): 443 - 448.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-S. Yang, C. Yu, H.-C. Chuang, C.-W. Chang, G.-D. Chang, T.-P. Yao, and H. Chen
FBW2 Targets GCMa to the Ubiquitin-Proteasome Degradation System
J. Biol. Chem., March 18, 2005; 280(11): 10083 - 10090.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. W. Schubert, E. Kardash, M. A. Khan, T. Cheusova, K. Kilian, M. Wegner, and S. Hashemolhosseini
Interaction, Cooperative Promoter Modulation, and Renal Colocalization of GCMa and Pitx2
J. Biol. Chem., November 26, 2004; 279(48): 50358 - 50365.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Hashemolhosseini and M. Wegner
Impacts of a new transcription factor family: mammalian GCM proteins in health and disease
J. Cell Biol., September 13, 2004; 166(6): 765 - 768.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
Y. Iwasaki, T. Hosoya, H. Takebayashi, Y. Ogawa, Y. Hotta, and K. Ikenaka
The potential to induce glial differentiation is conserved between Drosophila and mammalian glial cells missing genes
Development, December 15, 2003; 130(24): 6027 - 6035.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Sock, R. A. Pagon, K. Keymolen, W. Lissens, M. Wegner, and G. Scherer
Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia
Hum. Mol. Genet., June 15, 2003; 12(12): 1439 - 1447.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
M. Shimizu, H. Hiroaki, D. Kohda, T. Hosoya, Y. Akiyama-Oda, Y. Hotta, E. H. Morita, and K. Morikawa
NMR and ICP spectroscopic analysis of the DNA-binding domain of the Drosophila GCM protein reveals a novel Zn2+-binding motif
Protein Eng. Des. Sel., April 1, 2003; 16(4): 247 - 254.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Schreiber, E. Riethmacher-Sonnenberg, D. Riethmacher, E. E. Tuerk, J. Enderich, M. R. Bösl, and M. Wegner
Placental Failure in Mice Lacking the Mammalian Homolog of Glial Cells Missing, GCMa
Mol. Cell. Biol., April 1, 2000; 20(7): 2466 - 2474.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement